Oppenheimer Lowers Equifax (NYSE:EFX) Price Target to $286.00

Equifax (NYSE:EFX) had its price objective reduced by analysts at Oppenheimer from $315.00 to $286.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the credit services provider’s stock. Oppenheimer’s price target suggests a potential upside of 15.71% from the company’s current price.

A number of other analysts have also commented on EFX. Citigroup lifted their price target on Equifax from $263.00 to $304.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Barclays raised their price target on shares of Equifax from $300.00 to $380.00 and gave the company an “overweight” rating in a research note on Friday, September 13th. UBS Group began coverage on shares of Equifax in a research note on Tuesday, October 1st. They issued a “buy” rating and a $360.00 price objective on the stock. Morgan Stanley upped their price target on Equifax from $250.00 to $271.00 and gave the company an “equal weight” rating in a research report on Thursday, September 12th. Finally, BNP Paribas upgraded Equifax from an “underperform” rating to a “neutral” rating and set a $310.00 price objective for the company in a research report on Thursday, September 19th. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, Equifax has an average rating of “Moderate Buy” and an average price target of $306.74.

Equifax Stock Up 0.9 %

Shares of NYSE EFX opened at $247.18 on Tuesday. The stock has a 50-day moving average price of $279.56 and a two-hundred day moving average price of $267.68. Equifax has a 12 month low of $208.25 and a 12 month high of $309.63. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.96. The company has a market cap of $30.64 billion, a price-to-earnings ratio of 54.93, a PEG ratio of 2.34 and a beta of 1.59.

Equifax (NYSE:EFX) last issued its earnings results on Wednesday, October 16th. The credit services provider reported $1.85 earnings per share for the quarter, beating analysts’ consensus estimates of $1.84 by $0.01. The firm had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.44 billion. Equifax had a net margin of 10.07% and a return on equity of 18.56%. The company’s quarterly revenue was up 9.3% on a year-over-year basis. During the same quarter last year, the business posted $1.76 earnings per share. As a group, analysts forecast that Equifax will post 7.28 earnings per share for the current fiscal year.

Insider Transactions at Equifax

In other news, EVP John J. Kelley III sold 1,000 shares of the stock in a transaction that occurred on Friday, October 25th. The stock was sold at an average price of $272.92, for a total value of $272,920.00. Following the completion of the sale, the executive vice president now directly owns 11,269 shares of the company’s stock, valued at $3,075,535.48. This represents a 8.15 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Mark W. Begor sold 58,304 shares of Equifax stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $270.49, for a total value of $15,770,648.96. Following the transaction, the chief executive officer now directly owns 109,183 shares in the company, valued at approximately $29,532,909.67. The trade was a 34.81 % decrease in their position. The disclosure for this sale can be found here. 1.66% of the stock is currently owned by insiders.

Institutional Trading of Equifax

Institutional investors and hedge funds have recently modified their holdings of the business. Ashton Thomas Securities LLC bought a new stake in Equifax in the third quarter worth about $29,000. EntryPoint Capital LLC bought a new stake in Equifax in the 1st quarter valued at about $30,000. Tortoise Investment Management LLC boosted its position in Equifax by 76.1% during the second quarter. Tortoise Investment Management LLC now owns 125 shares of the credit services provider’s stock worth $30,000 after purchasing an additional 54 shares during the period. Mascoma Wealth Management LLC purchased a new position in shares of Equifax in the second quarter worth about $30,000. Finally, Crewe Advisors LLC raised its position in shares of Equifax by 138.2% in the second quarter. Crewe Advisors LLC now owns 131 shares of the credit services provider’s stock valued at $32,000 after purchasing an additional 76 shares during the period. 96.20% of the stock is owned by hedge funds and other institutional investors.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.